Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SOTKAMO SILVER: CONSTRUCTION OF TAILINGS PONDS AND ORE STORAGE AREAS HAVE BEEN COMPLETED

The clarification and tailings ponds of Silver Mine have been constructed in accordance with the lay-outs and regulations of the environmental permit. Launching of the ponds and water accumulation will commence in December. In total five settling ponds were built in addition to the tailings pond. At the same time, the intermediate storage areas for ore were also completed, which enables the mining of ore to be started. Construction work was carried out by E. Hartikainen Oy and membrane structures by Kaitos Oy. "The mining project is advancing according to the schedule, and completed

Technical issues regarding the press release service

Due to technical issues regarding the press release service, we currently do not have the opportunity to receive incoming press releases. If you wish to publish information, please contact us by telephone for manual handling. Phone number: 08 511 68 000 Ordering and trades work and are not affected by this technical problem. Spotlight Stock Market+ 46 8-511 68 000E-mail: pressmeddelanden@spotlightstockmarket.com About Spotlight Spotlight Stock Market is a market place that wants to make it easier, safer and more visible for growth companies to become and be listed. The

Notice of Extraordinary General Meeting of NeuroVive Pharmaceutical AB (publ)

The shareholders of NeuroVive Pharmaceutical AB (publ), 556595-6538, are hereby convened to the Extraordinary General Meeting, held at 1 pm on Thursday 17 January 2019 at Medicon Village, Scheelevägen 2, in Lund, Sweden.Entitlement to participate and notificationShareholders that wish to participate at the Extraordinary General Meeting should: · be included in the share register kept by Euroclear Sweden AB on Friday 11 January 2019, and · notify the company by email to anmalan@neurovive.com or, in writing to NeuroVive Pharmaceutical AB, Medicon Village, Scheelevägen 2, 223 81 Lund,

Follicum signs agreement with Centre for Skin Sciences at University of Bradford for Mode of Action studies

Follicum AB ("Follicum" or "Company"), a biotech company developing  new peptide drugs in two areas, hair loss and diabetes, today reports that a collaboration agreement with the Centre for Skin Sciences (CSS) at University of Bradford, UK, has been signed. The aim is to combine in vitro experiments with the use of bioinformatics data mining and analysis to investigate the mode of action of Follicum’s different peptide classes using an in silico approach (big data analysis). The scope of the project will cover both skin/hair biology and diabetes.Follicum has, as previously reported, made

Outcome of the Exercise of Warrants in NeuroVive

Lund, Sweden, 10 December 2018 –NeuroVive Pharmaceutical AB (publ) (“NeuroVive” or “the Company”) (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announces the outcome of the exercise of warrants of series 2018:1, issued in conjunction with the Company’s rights issue of units in April, 2018. The exercise period ended on 30 November 2018 and in total 126,235 warrants were exercised for the subscription of 126,235 shares at a subscription price of SEK 3.80 per share. Thus, NeuroVive will receive approximately TSEK 480 before issuance costs.Exercised warrants have been replaced with interim shares

NeuroVive resolves on a Rights issue of MSEK 123.8 for continued drug development, and new publication date of the 2018 Year End Report

Lund, Sweden, 10 December 2018 - NeuroVive Pharmaceutical AB (publ) (Nasdaq Stockholm: NVP, OTCQX: NEVPF) announces that the Board of Directors of NeuroVive Pharmaceutical AB (publ) ("NeuroVive" or "the Company") on 10 December 2018 resolved, subject to approval by the Extraordinary General Meeting, to issue shares with preferential rights to existing shareholders ("Rights issue") to enable continued drug development in its broad project portfolio. Upon full subscription to the Rights issue, the Company will receive approximately MSEK 123.8 before issuance costs. The Board of Directors of

TargetEveryone forecasts a 2019 full year revenue of MSEK 60

TargetEveryone finalized Beta version of its new Martech platform SpectrumOne on December 1st as planned. The company is now approaching customers with this new and unique software combining market analysis, customer segmentation and 1-1 communication features. The strategy is to approach the Norwegian market first, and quickly expand to Sweden by the first half year before further international expansion. Based on thorough market analysis, TargetEveryone has identified more than 1000 potential customers in the Swedish and Norwegian market. Considering that a SpectrumOne subscription to

Cantargia presents new positive preclinical data on antibody CAN04 at major antibody conference

Cantargia AB (publ) today announce that new preclinical data on the antibody CAN04 (nidanilimab) will be presented at the scientific conference Antibody Engineering and Therapeutics in San Diego Dec 9-13, 2018. CAN04 is in clinical development for cancer therapy and targets interleukin 1 receptor accessory protein, IL1RAP, positive single agent clinical data was recently presented at ESMO. The new results give further support for an important role of CAN04 also in combination with chemotherapy and provide new insights into the advantages of targeting IL1RAP as a treatment strategy in non-

2cureX is accelerating the launch of IndiTreat®

2cureX AB (“2cureX”) hereby announces that the clinical validation of IndiTreat® is running according to plan and that the company has identified a strategic possibility to accelerate the development of IndiTreat® and to prepare a pre-launch of the product on selected markets already during the second half of 2019 followed by a potential earlier than expected market launch. The pre-launch and a potential earlier than expected market launch will not only enhance the possibility of successful treatment of cancer patients but also enable to generate earlier cash flow for 2cureX. A pre-launch and

Dutch publisher alliance NLProfiel to use Cxense DMP as common data management platform

Oslo, Norway - 10 December, 2018 - Cxense ASA (OSE: CXENSE) today announced that three leading Dutch publishers Sanoma Media, Telegraaf Media Groep, and de Persgroep have signed an agreement to use Cxense DMP for their joint data alliance initiative NLProfiel. Together, the publishers reach over 60 percent of the Dutch population and run an average of 3.5 billion page views per month. The contract will make NLProfiel the largest Cxense customer in EMEA in terms of monthly page views and users. The publishers established NLProfiel in order to meet advertisers’ needs for standardized, high-

Karnov Group announces first-ever Nordic Audit and Accounting Award

Karnov Group, the Scandinavian market leader in providing unique and mission critical legal and tax information has announced the launch of its first-ever Nordic Audit and Accounting Award at the Nordic Accounting Conference 2018. The award is an additional step in the company’s mission to become the indispensable partner for all legal, tax, and accounting professionals in the Nordic region.Committed to providing unique and proprietary legal and tax information through a leading platform with more than 1,500 legal experts, Karnov Group reaffirms its role as an authority in the information

Alfa Laval wins SEK 140 million energy-efficiency order

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has won an order to supply compact heat exchangers to a petrochemical plant in the U.S. The order has a value of approximately SEK 140 million. It is booked in the Welded Heat Exchangers unit of the Energy Division, with deliveries scheduled for 2019 and 2020.The order comprises Alfa Laval compact heat exchangers which will be used to in the process of producing polymers, for further use in plastics products.  “Petrochemical processing is very energy intensive. By using energy-efficient heat

Bravida signs contract for the Stockholm Bypass Project

The Swedish Transport Administration and Bravida have signed a contract regarding electricity, lighting and HVAC on the Stockholm Bypass Project (FSE902), awarded to Bravida on August 28th. The contract has an order value of SEK 1.6 billion.The Stockholm Bypass Project is one of Sweden’s largest infrastructure projects ever. It will connect the southern and northern parts of the Stockholm County, relieving the city’s arterial roads of traffic.Bravida has signed the contract for Project FSE902, which includes all installations within power supply and electrical systems, equipment for

Scandic Hotels expands to Munich

Scandic Hotels, the largest hotel company in the Nordic countries, has signed a long-term lease agreement with developers Art-Invest Real Estate and Accumulata Real Estate regarding the operation of a new hotel, Scandic Munich Macherei.The hotel will be part of the new area “Macherei”, which will undergo a total transformation, from current industry area to an urban and vibrant neighborhood with space for art and culture, modern offices and open meeting and communication zones. It is located close to the city center and well-connected to the airport and the Neue Messe München exhibition

NENT Group’s latest original series is ‘Casper Conquers Norway’

· Original comedy series stars Casper Christensen (‘Klovn’) · ‘Casper Conquers Norway’ will premiere on Viaplay in autumn 2019 · NENT Group set to premiere 20 original productions every year Leading Danish comedian Casper Christensen will star in ‘Casper Conquers Norway’, the next original production from Nordic Entertainment Group (NENT Group). The eight-part ‘mockumentary’ (fictional documentary) series will premiere in autumn 2019 across the Nordic region exclusively on NENT Group’s streaming service Viaplay. After outraging the Danes with one scandalous joke too many, Casper

Outokumpu appoints Pia Aaltonen-Forsell as Chief Financial Officer

Outokumpu OyjStock exchange releaseDecember 10, 2018 at 9.30 am EET Outokumpu appoints Pia Aaltonen-Forsell as Chief Financial Officer Pia Aaltonen-Forsell, M. Soc. Sc. (Econ.), MBA, has been appointed Outokumpu’s Chief Financial Officer (CFO) and member of the Leadership Team as of March 1, 2019 reporting to CEO Roeland Baan. Outokumpu’s CFO Christoph de la Camp has decided to leave the company as of March 2019 due to personal reasons.  Aaltonen-Forsell joins Outokumpu from the role of CFO in Ahlström-Munksjö. Prior to her latest position, she has held CFO positions in Munksjö

Planmeca announces new dental unit

The new Planmeca Compact™ i5 dental unit has been built around five central themes – design, wellbeing, cleanliness, intelligence, and evolution.  All of these principles are carried through in every detail of the dental unit, resulting in a perfect combination of functionality, durability, comfort, safety, and aesthetics.Design – User-centric thinking Planmeca Compact i5 has been designed not only to withstand time, but also to evolve with time. Its compact and lightweight design complements any dental clinic and can be easily tailored to different working preferences. From smooth

Trading in Azelio’s share on Nasdaq First North commences today

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. Press release December 10, 2018Azelio AB (publ) (”Azelio” or the ”Company”), announces that the trading in the Company’s share on Nasdaq First North commences today under the short name “AZELIO” with ISIN SE0011973940. Prior to the listing, Azelio has completed a share issue that

ÅF and Pöyry to join forces – forming a leading European engineering and consulting company

This stock exchange release may not be released, published or otherwise distributed, in whole or in part, in or into, directly or indirectly, Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction in which the tender offer would be prohibited by applicable law.ÅF AB (publ) (“ÅF”) and Pöyry PLC (“Pöyry”) have signed an agreement (the “Combination Agreement”) to combine the two companies to form a leading European engineering and consulting company. ÅF will launch a recommended public cash tender offer to purchase all issued and outstanding shares in

Share buy-backs in Telia Company during week 49 2018

During the period December 3, 2018, until December 7, 2018, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 2,775,000 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back programme that Telia Company announced on April 20, 2018. The share buy-back programme, which runs between April 23, 2018, and March 22, 2019, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").During the period

European investor InnoEnergy expands its involvement in Minesto with €1m investment

European powerhouse and investor in clean energy InnoEnergy expands its involvement in Swedish marine energy developer Minesto. InnoEnergy has awarded an additional €1 million to the commercialisation of Minesto’s unique marine energy technology, making Minesto InnoEnergy’s largest investment in ocean energy.“This investment underlines the role of ocean energy by Minesto’s technology in the global transition to a renewable energy system. It’s a clear sign of confidence from InnoEnergy in the capabilities of our organisation and in the potential our disruptive clean energy technology. As a

NEXT Biometrics and LastMile Mobi to Jointly Develop New Biometric-Enabled Products

OSLO, Dec. 10, 2018 – NEXT Biometrics (Oslo Bors: NEXT), a global leader in fingerprint sensor technology, today announced a cooperation agreement with Digitsecure India Pvt Ltd(www.lastmile.mobi) where the two companies will work together to develop new products based on NEXT’s advanced, large-area fingerprint sensor technology. Specific product information and detailed objectives for the joint project are not being disclosed at this time. Digitsecure is an India-based Digital identity and payments processing company with specialized focus on EMV, Biometrics, Card payments and security.

HPV type 16 or 18 in young women predicts risk of cervical cancer

[PRESS RELEASE 2018-12-10] The human papilloma virus (HPV) can cause cervical cancer. According to new guidelines in Sweden, women over thirty therefore undergo initial screening for the virus rather than a smear test. But younger women also have a much higher risk of pre-cancerous lesions if they carry HPV 16 or 18, a study from Karolinska Institutet in Sweden published in the scientific journal Cancer shows.Four out of five women of fertile age are infected at some time in their lives with HPV. Most of these infections clear on their own, but for some five per cent of the women, the

Selvaag Bolig ASA: Notifiable trades for primary insiders

A total of 41 Selvaag Bolig employees have purchased 470 509 shares through the company's share-saving programme and purchase programme for selected senior executives. The shares had a purchase price of NOK 37.83 per share A total of 75 employees were offered the opportunity to buy shares worth up to NOK 200 000 through the company's share-saving programme. The offer included a discount of 20 per cent on the shares as well as financing assistance. The lock- up period is two years.Five senior executives were offered the opportunity to acquire shares worth up to one year's salary through

There are no items matching the current filter
There are no more items matching the current filter
Back to top